Literature DB >> 17945351

Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells.

Lian Li1, Sheng-Ping Li, Jun Min, Limin Zheng.   

Abstract

Tumor cells may escape from the immune responses because of defective differentiation of dendritic cells (DC). Recent studies have found an increased number of regulatory T cells (Treg) in both peripheral blood and tissues from patients with hepatocellular carcinoma. In the present study, we used tumor culture supernatants (TSN) from hepatoma-derived cell lines to investigate whether TSN interfere with the differentiation of human monocyte-derived DC and/or their ability to increase Treg. The results showed that exposure to TSN significantly inhibited the differentiation of monocytes into DC with retained CD14 molecule and reduced expression of CD1a. These TSN-exposed immature DC also produced significant amount of immunosuppressive cytokine IL-10 and displayed an increased expression of co-stimulatory molecules. Upon stimulation with LPS, however, the TSN-exposed DC failed to undergo full maturation, with a blockage of the upregulation of co-stimulatory molecules on their surface and a switch to an IL-10(high)IL-12(low)TNF-alpha(low) phenotype. Moreover, exposure of DC to TSN selectively inhibited their capacity to stimulate the proliferation of allogeneic CD8(+) T cells, but promoted the generation of CD4(+)CD25(hi)Foxp3(+) Treg cells. These findings, together with previous clinical studies showing that CD4(+)CD25(hi) Treg cells are concentrated within hepatocellular carcinoma tissue, suggest that the local tumor microenvironment may favor the induction of Treg cells through inhibiting the differentiation and maturation of DC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945351     DOI: 10.1016/j.imlet.2007.09.003

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  5 in total

1.  N-3-(oxododecanoyl)-L-homoserine lactone promotes the induction of regulatory T-cells by preventing human dendritic cell maturation.

Authors:  Youqiang Li; Huayou Zhou; Yunyan Zhang; Cha Chen; Bin Huang; Pinghua Qu; Jianming Zeng; E Shunmei; Xuan Zhang; Jianping Liu
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-06

Review 2.  Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.

Authors:  Tim Chan; Robert H Wiltrout; Jonathan M Weiss
Journal:  Int Immunopharmacol       Date:  2011-01-15       Impact factor: 4.932

Review 3.  Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.

Authors:  Angelo Aquino; Grazia Graziani; Ornella Franzese; Salvatore P Prete; Enzo Bonmassar; Laura Bonmassar; Stefania D'Atri
Journal:  Clin Dev Immunol       Date:  2011-03-22

4.  In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.

Authors:  Shigeo Koido; Sadamu Homma; Eiichi Hara; Makoto Mitsunaga; Yoshihisa Namiki; Akitaka Takahara; Eijiro Nagasaki; Hideo Komita; Yukiko Sagawa; Toshifumi Ohkusa; Kiyotaka Fujise; Jianlin Gong; Hisao Tajiri
Journal:  J Transl Med       Date:  2008-09-15       Impact factor: 5.531

5.  Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy.

Authors:  Tan-Huan Chen; Ying-Chun Zhang; Yu-Ting Tan; Xin An; Cong Xue; Ying-Fei Deng; Wei Yang; Xia Yuan; Yan-Xia Shi
Journal:  Oncotarget       Date:  2017-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.